Blurbs

Analysts’ Opinions Are Mixed on These Technology Stocks: Alphabet Class A (GOOGL), Lockheed Martin (LMT) and GoodRx Holdings (GDRX)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Alphabet Class A (GOOGLResearch Report), Lockheed Martin (LMTResearch Report) and GoodRx Holdings (GDRXResearch Report).

Alphabet Class A (GOOGL)

In a report released today, Brent Thill from Jefferies maintained a Buy rating on Alphabet Class A, with a price target of $155.00. The company’s shares closed last Wednesday at $113.90.

According to TipRanks.com, Thill is ranked 0 out of 5 stars with an average return of -8.1% and a 30.7% success rate. Thill covers the Technology sector, focusing on stocks such as Instructure Holdings, IAC/InteractiveCorp., and Procore Technologies.

Currently, the analyst consensus on Alphabet Class A is a Strong Buy with an average price target of $150.57, implying a 33.0% upside from current levels. In a report issued on July 7, Evercore ISI also maintained a Buy rating on the stock with a $155.50 price target.

See the top stocks recommended by analysts >>

Lockheed Martin (LMT)

In a report released yesterday, Sheila Kahyaoglu from Jefferies maintained a Hold rating on Lockheed Martin, with a price target of $470.00. The company’s shares closed last Wednesday at $395.22.

According to TipRanks.com, Kahyaoglu is a 4-star analyst with an average return of 3.8% and a 54.2% success rate. Kahyaoglu covers the Technology sector, focusing on stocks such as Raytheon Technologies, L3Harris Technologies, and Spirit AeroSystems.

Lockheed Martin has an analyst consensus of Moderate Buy, with a price target consensus of $474.38, which is a 21.4% upside from current levels. In a report issued on July 7, Cowen & Co. also maintained a Hold rating on the stock with a $470.00 price target.

GoodRx Holdings (GDRX)

In a report released yesterday, Glen Santangelo from Jefferies maintained a Buy rating on GoodRx Holdings, with a price target of $9.00. The company’s shares closed last Wednesday at $7.10, close to its 52-week low of $5.62.

According to TipRanks.com, Santangelo is a 5-star analyst with an average return of 15.2% and a 64.3% success rate. Santangelo covers the Technology sector, focusing on stocks such as Tabula Rasa HealthCare, Health Catalyst, and Accolade.

Currently, the analyst consensus on GoodRx Holdings is a Hold with an average price target of $10.31, a 48.3% upside from current levels. In a report issued on July 18, Guggenheim also maintained a Buy rating on the stock with a $13.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on GOOGL:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos